Study identifier:NIS-NKR-SER-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A 8-week, Multicenter, Open-label, Observational Study of Atypical antipsychotics in improvement of quality of life in Bipolar disorder
Naturalistic
-
No
-
All
1000
Observational
18 Years - 65 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|